Samsrita Labs Ltd

(539267)

Dr Habeebullah Life Sciences Limited was incorporated in January 251996 and is engaged in the natural sciences, engineering, biotech, and hospital services research and development. In 2015, the company underwent a change of registered office from Karnataka to Telangana. In 2016, the company underwent restructuring in terms of capital change in promoters shareholding and change in management after they decided to acquire not less than 51 stake in M/s. Krisani Bio Sciences Private Limited. Dr. Mohammed Aejaz Habeeb, Acquirer 1, Dr. Syed Ameer Basha Paspala, Acquirer 2, and K. Krishnam Raju, Acquirer 3, triggered an open offer, offering to purchase 2667300 Equity Shares of Rs. 10/ each to acquire 26% of the Emerging Equity Share Capital/Voting Capital of the Target Company. By the end of the year, the Company had acquired one subsidiary, Krisani Bio Sciences Private Limited. Since then, the Company has only reportable segment i.e. the BioPharma Sector. During the FY 2016/17, the Paid up Capital of the Company increased from 10,258,706 to 11,758,706 and to 13,808,706 during the FY 2018/19 as Equity Shares were allotted to Non Resident Indians and Convertible Equity Share Warrants to Promoters of the Company as well as Non Promoters. The Company also entered into Collaborative Agreements with its Subsidiary Krisani Bio Sciences Private Limited and Centre for Liver Research And Diagnostics CLRD, and paid the penalty of Rs. 400,000 to the Securities Exchange Board of India when they were found to have not complied with the provisions of Regulation 83 of SEBI Substantial Acquisition of Shares and Takeovers Regulations 1997.

Share Price: ₹24.51 per share as on 21 Oct, 2024 04:01 PM
Market Capitalisation: ₹37.04Cr as of today
Revenue: ₹0.00Cr as on September 2021 (Q3 21)
Net Profit: ₹0.02Cr as on September 2021 (Q3 21)
Chairperson Name: K Krishnam Raju